NEWS RELEASE: Muroski Named President of Trelleborg Medical Solutions
Trelleborg Medical Solutions Business Area President Linda Muroski [Photo courtesy of Trelleborg]
“The healthcare and medical market segment within the Group has grown successfully for several years. We are now establishing a platform from which we intend to grow further. With the recently signed acquisition of Baron Group and the upcoming new facility in Costa Rica, the market segment will represent a larger share of the Group’s sales. Linda Muroski, who has successfully led the Global Healthcare & Medical business within Trelleborg Sealing Solutions for several years, will become President of the new business area and will join the Group Management,” says Peter Nilsson, President and CEO of Trelleborg.
With a keen eye for growth opportunities, Muroski helped form the global Healthcare & Medical business unit in 2019, assembling an astute leadership team and quickly integrating four acquired businesses.
Trelleborg Medical Solutions consists of 14 production facilities that serve customers’ needs across every phase of the medical device development cycle from concept to full production.
Muroski says: “The formation of Trelleborg Medical Solutions gives us increased strategic direction to support our customers. It signifies our commitment to the healthcare and medical industry, and I’m honored to help foster that direction and commitment in this new role.”
Muroski has experience in quality, sales and marketing, manufacturing, supply chain, and project management. She joined Trelleborg in 2016 and most recently served dual roles as Trelleborg’s President Marketing Americas and President Global Healthcare and Medical. Over the past 25 years, Muroski has worked for Johnson Controls, Engelhard and BASF. She holds a Master of Business Administration from Pennsylvania State University and a Bachelor of Science from Ramapo College of New Jersey in business administration and marketing.
About Trelleborg Medical Solutions and Trelleborg Group
Trelleborg Medical Solutions helps pharmaceutical and medical device companies improve patient quality of life. It does this by forming lasting partnerships with customers to develop innovative, reliable engineered polymer solutions for demanding medical, biotech and pharmaceutical applications. From a single global source, backed by the expertise of a worldwide engineering and manufacturing network, it partners with its customers in all stages of development, from concept to serial production, providing the optimum solutions to meet all their partners polymer-based healthcare & medical application challenges. Trelleborg Medical Solutions combines a number of operations from within Trelleborg Group that are focused on this industry. www.trelleborg.com/en/healthcare
Trelleborg is a world leader in engineered polymer solutions that protect critical applications in demanding environments. Its innovative solutions accelerate performance for customers in a sustainable way. In 2023, the Trelleborg Group had annual sales of approximately SEK 34 billion in around 40 countries. The Group comprises three business areas: Trelleborg Industrial Solutions, Trelleborg Sealing Solutions and Trelleborg Medical Solutions. The Trelleborg share has been listed on the Stock Exchange since 1964 and is listed on Nasdaq Stockholm, Large Cap. www.trelleborg.com
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
